Polyclonal Rabbit anti‑Rat CHGB / Chromogranin B Antibody (Cy3, aa315‑482, WB) LS‑C702994
Polyclonal Rabbit anti‑Rat CHGB / Chromogranin B Antibody (Cy3, aa315‑482, WB) LS‑C702994
Antibody:
CHGB / Chromogranin B Rabbit anti-Rat Polyclonal (aa315-482) (Cy3) Antibody
Overview
Antibody:
CHGB / Chromogranin B Rabbit anti-Rat Polyclonal (aa315-482) (Cy3) Antibody
Specifications
Description
Chromogranin B antibody LS-C702994 is a Cy3-conjugated rabbit polyclonal antibody to rat Chromogranin B (CHGB) (aa315-482). Validated for WB.
Target
Rat CHGB / Chromogranin B
Synonyms
CHGB | Chromogranin-B | Chromogranin B | Secretogranin B | Secretogranin I | Secretogranin-1 | SGI | SCG1
Reactivity
Rat
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant CHGB (Tyr315-Lys482) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against CHGB.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CHGB / Chromogranin B
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot
Reactivity:
Human
Range:
0.625-40 ng/ml
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, Immunoprecipitation, ELISA
Reactivity:
Bovine
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024